OpenVSafe by OpenVAERS
Search V-safe

HDM-23263-88499

2 vaccinations 2 coded responses 14 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
222 / VA
Registered
2021-10-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
FFV-11220-71023 Child or adolescent in my care · Male · 2022-07-02

Timeline

  1. 2021-04-10
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-10-22
    Registered in v-safe
  3. 2021-10-22
    Dose 2 — Pfizer-BioNTech
  4. 2021-10-22
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-10-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-10-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-10-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  8. 2021-10-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2021-10-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2021-10-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-11-05
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-11-12
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-11-19
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-11-26
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-12-03
    Survey response — day 42, dose 2
    MedDRA: Oropharyngeal pain — Feeling: Fair
    Free text: Sore throat
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-01-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-04-24
    Survey response — 6 months, dose 2
    MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Tested positive for COVID mid-Feb
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-04-24
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  19. 2022-04-26

Vaccinations

DoseDateManufacturerCo-administered
12021-04-10Janssen/Johnson & Johnson No
22021-10-22Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — day 42, dose 2

2021-12-03

Symptoms: Sore throat

Release 11 — 6 months, dose 2

2022-04-24

Symptoms: Tested positive for COVID mid-Feb

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDOropharyngeal pain · · ✓
SDSARS-CoV-2 test positive · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…